Search

764 Result(s)
Sort by

BIVF funding more than doubled to 250 M€

BIVF funding more than doubled to 250 M€

Boehringer Ingelheim increases funding for its corporate venture fund, the Boehringer Ingelheim Venture Fund (BIVF), from EUR 100 to 250 million
Kobe

Kobe

The Kobe Pharma Research Institute takes part in the global research and development activities for human pharmaceuticals.
Yamagata

Yamagata

The site in Yamagata, Japan, is dedicated to the production of human pharmaceutical products for the Japanese market.
Anna Race

Anna Race

Anna Race, Sales Director, Human Pharma, UK & Ireland, tells us how a career in our Commercial Division helps her to make a difference.
Our partners university of georgia

Our partners university of georgia

We're partnering with the University of Georgia to address unmet needs and find solutions to some of the biggest challenges in animal health.
Rabies? Not in Mexico!

Rabies? Not in Mexico!

Mexico has been a rabies-free country for the last five years. How does Mexico achieve this? Learn how we're collaborating in this fight against rabies.
Life stages of cats

Life stages of cats

Cats go through different stages of life. Knowing more about these stages can help you understand your cat’s medical needs better.
Boehringer Ingelheim annouces 2020 BVDzero Case Awards

Boehringer Ingelheim annouces 2020 BVDzero Case Awards

Boehringer Ingelheim is announcing the 2020 ‘BVDzero Case Awards’ are now open for applications. The bi-annual awards reflect the long-term commitment to promoting the health and well-being of farm animals.